Key result
HRT linked to lower arterial pulsatility index, plasma thromboxane, and viscosity in postmenopausal women.
Why the study?
The relationship between plasma thromboxane, plasma viscosity, and Doppler flow parameters in postmenopausal patients undergoing hormone replacement therapy was evaluated.
Does hormone replacement therapy improve Doppler flow parameters, thromboxane, and plasma viscosity in postmenopausal women?
Observational (n=32)
Does hormone replacement therapy improve Doppler flow parameters, thromboxane, and plasma viscosity in postmenopausal women?
Hormone replacement therapy in postmenopausal women significantly reduces arterial pulsatility index, plasma thromboxane, and plasma viscosity, suggesting beneficial modifications in vessel wall physiology.
The aim of the study was to evaluate the plasma thromboxane and plasma viscosity in relation with Doppler flow parameters in postmenopausal patients treated with hormone replacement therapy. Thirty-two postmenopausal (follicle-stimulating hormone > 40 IU/l and estradiol < 100 pmol/l) women (mean age +/- SD, 54.7 +/- 2.9 years) participated in the study and were submitted to continuous estradiol transdermal supplementation and 12-day courses of medroxyprogesterone acetate every second month. Doppler resistances at the level of the uterine and internal carotid arteries, thromboxane plasma levels and plasma viscosity were analyzed in basal condition and after 1, 3 and 6 months. During hormone supplementation, the pulsatility index significantly decreased at the level of the analyzed arteries. Similarly, plasma thromboxane levels and plasma viscosity were significantly reduced. Significant correlations were found between thromboxane plasma concentrations, plasma viscosity and uterine artery resistances. Thus hormone replacement therapy seems to be responsible for both direct and indirect modifications at the level of the vessel wall physiology.
No takes yet. Share an insight, caveat, or question.
Battaglia et al. (1999) conducted an observational in Postmenopausal (n=32). Hormone replacement therapy vs. Basal condition was evaluated on Doppler resistances, thromboxane plasma levels, and plasma viscosity. Hormone replacement therapy significantly reduced arterial pulsatility index, plasma thromboxane levels, and plasma viscosity in postmenopausal women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: